FcRider-based Expression and Delivery of Stable Env Immunogens for HIV Vaccines
Award Notice Posted
- Solicitation number
- 75N93022C00011
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Antagen Biosciences Inc.
- Set-aside
- Total Small Business
Opportunity facts
- Contract number
- 75N93022C00011 Federal contract award
- Place of performance
- Boston, Massachusetts 02118, United States
Notice details come from SAM.gov. Updated .
About this opportunity
Antagen Pharmaceuticals, Inc. was awarded a $299,998 contract by the National Institute of Allergy and Infectious Diseases to support their research and development efforts for expressing and delivering stable HIV envelope immunogens using an FcRider platform technology over the course of one year. This contract will advance the agency's work in HIV vaccine development by funding the contractor to further develop their FcRider-based Expression and Delivery of Stable Env Immunogens for HIV Vaccines.
Notice text
Awarded contract 75N93022C00011 to Antagen Pharmaceuticals, Inc. for 299998.00 on 2022-07-01.
Notice history
6 of 8 notices listed here. See the rest on GovTribe.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity